IS1-4 Stable Galectin-9 as a Next-Generation Therapeutics for Allergic and Autoimmune Diseases(IS1 What Are the Strategies for Preventing and Curing Allergy?)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本アレルギー学会の論文
- 2008-10-30
著者
関連論文
- Persistent Elevation of Plasma Osteopontin Levels in HIV Patients Despite Highly Active Antiretroviral Therapy
- Characterization of Galectin-9-Induced Death of Jurkat T Cells
- Quantification of Galectin-7 and Its Localization in Adult Mouse Tissues
- Heterogeneous chemotactic response of eosinophils in patients with bronchial asthma: Its association with disease severity
- Enhancement of Anti-tumor Activity of Natural Killer Cells by BALL-1, a B Cell Lymphoma Line
- IS1-4 Stable Galectin-9 as a Next-Generation Therapeutics for Allergic and Autoimmune Diseases(IS1 What Are the Strategies for Preventing and Curing Allergy?)
- Short-term stimulation with interleukin (IL)-4 enhances purified protein derivative-induced production of an eosinophil chemotactic lymphokine, but suppresses IL-5 production
- CD35 expression on peripheral blood granulocytes of patients with atopic dermatitis
- Rapid Decrease of Plasma Galectin-9 Levels in Patients with Acute HIV Infection after Therapy